Introduction {#section1-1076029620907954}
============

Venous thromboembolism (VTE), which includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is a common problem associated with both significant morbidity and mortality. With an estimated annual incidence of 1 to 4 per 1000 persons,^[@bibr1-1076029620907954][@bibr2-1076029620907954][@bibr3-1076029620907954]--[@bibr4-1076029620907954]^ VTE is a leading cause of cardiovascular death.^[@bibr5-1076029620907954]^ Patients admitted to intensive care units (ICUs) are at high risk of VTE. Incidences of DVT and PE in adult ICU patients have been reported to be 20 per 1000 patients,^[@bibr6-1076029620907954]^ although this number does not take into account undiagnosed or asymptomatic VTEs. Patients in neurologic intensive care units (NICUs) tend to be bedridden and to have long-term stays, while many have varying degrees of paralysis and coma. The risk of VTE in NICU patients is presumed to be high. Blood stasis caused by paralysis and prolonged coma may be the main cause for this. Additionally, endothelial dysfunction and clotting system abnormalities, which may be a result of cerebrovascular diseases, malignancies, or inflammatory diseases of the nervous system, also contribute to the high risk of VTE.^[@bibr7-1076029620907954]^ However, exact incidences of DVT and PE in adult NICU patients have not yet been reported.

In 2016, the Neurocritical Care Society (NCS) announced evidence-based guidelines concerning VTE prophylaxis for neurocritical care patients. This was the first statement to provide guidance about VTE, specifically for NICU patients.^[@bibr7-1076029620907954]^ Nevertheless, many points of this guideline are not yet supported by solid and high-quality evidence. Thus, it is crucial to investigate the incidence and characteristics of VTE in adult NICU patients.

Therefore, in this study, we aimed to investigate the incidence and characteristics of VTE---including DVT and PE---in NICU patients as well as to determine risk factors for VTE in these patients.

Patients and Methods {#section2-1076029620907954}
====================

Study Design and Setting {#section3-1076029620907954}
------------------------

Patients admitted to the NICU of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China, between April 1, 2018, and January 31, 2019, were enrolled in this prospective observational study. The NICU has 18 beds for neurological patients who are critically ill. Patients with brain trauma are not routinely accepted. This study is aligned with the principles of the 1964 Declaration of Helsinki and its later amendments and was approved by the institutional review board of the hospital (no. TJ-IRB20180702). All patients (or their relatives) gave written informed consent.

Study Population {#section4-1076029620907954}
----------------

Consecutive patients who met both of the following criteria were included: (1) length of NICU stay ≥1 week and (2) being bedridden due to paralysis and/or unconsciousness ≥1 week. Exclusion criteria were as follows: (1) unstable vital signs, (2) unable to wean from mechanical ventilation, (3) renal insufficiency, (4) hypersensitivity to iodinated contrast media, (5) patient or relatives could not give informed consent, and (6) study examinations could not be completed for any reason.

All participants received positive DVT prevention measures, including intermittent pneumatic compression (IPC) and passive limb exercises. Regarding those critically ill patients who were immobile due to neurologic injury, the plan for chemical DVT prophylaxis was determined based on the NCS VTE prophylaxis guideline.^[@bibr7-1076029620907954]^ Considering the associated risk from bleeding due to standard VTE prophylaxis and existing bleeding contraindications (such as stress ulcer bleeding or hemorrhagic conversion of strokes), individualized timing and administration of chemical DVT prophylaxis via subcutaneous low-molecular-weight heparin (LMWH) was determined by a clinical team of trained neurologists.

Data Collection {#section5-1076029620907954}
---------------

The following information was collected from medical records: sex, age, date of admission, primary diagnosis, comorbidities and complications, degree of paralysis, Glasgow Coma Scale (GCS) score, plasma homocysteine level, serum [d]{.smallcaps}-dimer levels both on admission and after 1 week of NICU hospitalization, treatments, and prognosis. Assessment and grading of VTE risk was carried out using the Caprini scoring system.^[@bibr8-1076029620907954]^ In this system, 0 to 1 indicates low risk, 2 moderate risk, 3 to 4 higher risk, and 5 or more highest risk of VTE.

Measurements of DVT and PE {#section6-1076029620907954}
--------------------------

Patients were screened for VTE on days 7 to 10 of hospitalization. The symptoms of DVT such as limb swelling and pain were observed and recorded. Color Doppler venous ultrasonography of the extremities was used for DVT diagnosis. Patients were also observed for respiratory and circulatory signs of a PE. Computed tomography pulmonary angiography (CTPA) was used for PE diagnosis.

Statistical Analysis {#section7-1076029620907954}
--------------------

Measurement data are expressed as mean ± standard deviation, while enumeration data are expressed as count and percentage. In the univariate analysis of risk factors, Student *t* test was used to evaluate measurement data, while Pearson χ^2^ test, Continuity Correction, or Fisher exact test was used for analysis of enumeration data. Variables with a value of *P* \< .1 were included in the multivariate analysis. Logistic regression (enter regression) was applied for multivariate analysis, where *P* \< .1 indicated statistical significance. All analyses were performed using SPSS version 19.0 software (2010, IBM SPSS Statistics for Windows, IBM Corp, Armonk, New York).

Results {#section8-1076029620907954}
=======

Patient General Characteristics {#section9-1076029620907954}
-------------------------------

A total of 126 NICU patients were included in this study. Mean patient age was 54 years (range: 16-90) and there were 85 males and 41 females. The most common admission diagnoses were intracerebral hemorrhage (ICH), ischemic stroke, and intracranial infection. Ninety-one (72.2%) patients developed 1 or more complications during their NICU stay. Sixty-five (51.6%) had comorbidities, which were primarily chronic diseases. Most (83.3%) patients had varying degrees of paralysis, with coma being commonly presented. The GCS score of patients ranged from 5 to 15, with a mean of 11. Based on GCS score, 24.6% of patients had severe coma (GCS 3-8). Caprini scores ranged from 1 to 15, with a mean of 9. Approximately 95% of patients had a Caprini score ≥3. Patient data are summarized in [Table 1](#table1-1076029620907954){ref-type="table"}.

###### 

Patient General Characteristics.

![](10.1177_1076029620907954-table1)

  Variables                        Patients
  -------------------------------- ------------
  Age, years                       54 (16-90)
  Ratio, male/female               85/41
  Admission diagnosis, n (%)       
   ICH                             57 (45.2)
   Ischemic stroke                 39 (31.0)
   Intracranial infection          17 (13.5)
   Ischemic hypoxic cerebropathy   3 (2.4)
   GBS                             2 (1.6)
   SAH                             2 (1.6)
   Status epilepticus              2 (1.6)
   Multiple system atrophy         1 (0.8)
   CVST                            1 (0.8)
   TBI                             1 (0.8)
   MG                              1 (0.8)
  Complications, n (%)             
   Pulmonary infection             81 (64.3)
   Epilepsy                        7 (5.6)
   Gastrointestinal bleeding       13 (10.3)
   Electrolyte imbalance           7 (5.6)
   MODS                            4 (3.2)
   Angiitis                        6 (4.8)
   Others                          23 (18.3)
  Comorbidities, n (%)             
   Hypertension                    55 (43.7)
   Atrial fibrillation/flutter     5 (4.0)
   Diabetes                        11 (8.7)
   Hepatitis B                     7 (5.6)
   Coronary heart disease          4 (3.2)
   COPD                            5 (4.0)
  Paralysis, n (%)                 
   Hemiplegia                      61 (48.4)
   Quadriplegia                    30 (23.8)
   Quadriparesis                   11 (8.7)
   Paraplegia                      3 (2.4)
  GCS score, n (%)                 
   9-15                            95 (75.4)
   3-8                             31 (24.6)
  Caprini score, n (%)             
   0-2                             6 (4.8)
   ≥3                              120 (95.2)
  Plasma HCY, n (%)                
   Normal                          83 (65.9)
   Hyperhomocysteinemia            43 (34.1)
  NICU mortality, n (%)            2 (1.6)

Abbreviations: COPD, chronic obstructive pulmonary disease; CVST, cerebral venous sinus thrombosis; GBS, Guillain-Barre syndrome; GCS, Glasgow Coma Scale; HCY, homocysteine; ICH, intracerebral hemorrhage; MG, myasthenia gravis; MODS, multiple organ dysfunction syndrome; NICU, neurologic intensive care unit; SAH, subarachnoid hemorrhage; TBI, traumatic brain injury.

Deep Vein Thrombosis {#section10-1076029620907954}
--------------------

After 1 week of NICU hospitalization, the use of ultrasonography revealed DVT in 45 patients, meaning DVT incidence was 35.7%. Approximately 76% of the DVTs were located in the muscular calf vein, while 11% were in the femoral vein and 2% in the iliac vein (iliofemoral DVT). Other veins in which DVT was located included superficial femoral, posterior tibial, fibular, popliteal, internal jugular, subclavian, axillary, and brachial. Approximately 13% of DVTs were related to central venous catheterization. It is noteworthy that just 2 DVT patients had symptoms such as limb swelling and pain. The other 95.6% were asymptomatic. Some 24.4% of DVT patients had a concurrent PE. The characteristics of DVT are summarized in [Table 2](#table2-1076029620907954){ref-type="table"}.

###### 

Incidence and Characteristics of Deep Venous Thrombosis and Pulmonary Embolism at 1 Week of Neurologic Intensive Care Unit Hospitalization.

![](10.1177_1076029620907954-table2)

  Variables                   Patients
  --------------------------- ----------------
  DVT incidence at 1 week     45/126 (35.7%)
  Location of DVT             
   Femoral vein               5/45 (11.1%)
   Iliac vein                 1/45 (2.2%)
   Superficial femoral vein   1/45 (2.2%)
   Posterior tibial vein      3/45 (6.7%)
   Fibular vein               1/45 (2.2%)
   Popliteal vein             1/45 (2.2%)
   Muscular calf vein         34/45 (75.6%)
   Internal jugular vein      1/45 (2.2%)
   Subclavian vein            1/45 (2.2%)
   Axillary vein              2/45 (4.4%)
   Brachial vein              3/45 (6.7%)
   Central venous catheter    6/45 (13.3%)
  Symptoms of DVT             
   Symptomatic                2/45 (4.4%)
   Asymptomatic               43/45 (95.6%)
  Concurrent with PE          
   With PE                    11/45 (24.4%)
   Without PE                 34/45 (75.6%)
  PE incidence at 1 week      22/126 (17.5%)
  Location of PE              
   Main pulmonary artery      5/22 (22.7%)
   Pulmonary artery branch    17/22 (77.3%)
  Symptoms of PE              
   Symptomatic                3/22 (13.6%)
   Asymptomatic               19/22 (86.4%)
  Concurrent with DVT         
   With DVT                   11/22 (50.0%)
   Without DVT                11/22 (50.0%)

Abbreviations: DVT, deep venous thrombosis; PE, pulmonary embolism.

Pulmonary Embolism {#section11-1076029620907954}
------------------

After 1 week of NICU hospitalization, PE was diagnosed in 22 patients by CTPA, meaning there was an incidence of 17.5%. Some 22.7% of PEs were located in the main pulmonary arteries, while the rest (77.3%) were in the pulmonary artery branches. Similar to the DVTs, most PEs (86.4%) were asymptomatic; only 3 (13.6%) patients presented with respiratory system and/or circulatory system symptoms, including dyspnea, hypoxemia, and severe arrhythmia. Of the PE patients, 50% had a concurrent DVT. The characteristics of PE are listed in [Table 2](#table2-1076029620907954){ref-type="table"}.

Venous Thromboembolism in Severe ICH Patients {#section12-1076029620907954}
---------------------------------------------

Intracerebral hemorrhage patients are at high risk of VTE. Treating ICH patients with a VTE is complex as anticoagulant therapy increases the risk of recurrent bleeding and hematoma enlargement. Therefore, a subgroup analysis of ICH patients was carried out. There were 57 severe ICH patients in the study, with a mean age of 55 years and a male to female ratio of 40:17. Among these, 59.6% (34/57) of the hematomas were located in the basal ganglia or lobes, while 21.1% (12/57) were in the brainstem, 12.3% (7/57) were in the ventricular system, 5.3% (3/57) were in the cerebellum, and 1.8% (1/57) were in the subdural space. More than half of the ICH patients underwent surgery, including microinvasive craniopuncture therapy (52.6%), ventricular drainage (7.0%), and craniotomy evacuation of the hematoma (3.5%).

In this subgroup, DVT incidence at 1 week was 31.6% (18/57), with 77.8% (14/18) of DVTs located in the muscular calf vein. Other locations were the femoral (11.1%), superficial femoral (5.6%), posterior tibial (11.1%), popliteal (5.6%), internal jugular (5.6%), and brachial (5.6%) veins. Most (88.9%) DVTs were asymptomatic. Of the 18 patients with a DVT, 5 (27.8%) had a concurrent PE.

After 1 week of NICU hospitalization, PE incidence in severe ICH patients was 12.3% (7/57). Approximately 14% of the PEs were in the main pulmonary arteries, while the remainder (85.7%) were in the pulmonary artery branches. Only 1 patient with PE presented with dyspnea and cardiac arrest; all others were asymptomatic. Approximately 71% of the PE patients also had a DVT.

Risk Factors for VTE {#section13-1076029620907954}
--------------------

Results of the univariate analysis of DVT risk factors are summarized in [Table 3](#table3-1076029620907954){ref-type="table"}. Demographic data and the distribution of most variables were similar in patients with and without a DVT. The percent of patients with paralysis, raised [d]{.smallcaps}-dimer on admission, and pulmonary infection were significantly higher in the DVT group than in those without a DVT. In the multivariate logistic regression analysis, paralysis, raised [d]{.smallcaps}-dimer on admission, and pulmonary infection were found to be independent risk factors for DVT in NICU patients ([Table 4](#table4-1076029620907954){ref-type="table"}).

###### 

Univariate Analysis of Risk Factors of Deep Venous Thrombosis.
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  Variables                                   DVT (+), n = 45   DVT (−), n = 81   *P* Value
  ------------------------------------------- ----------------- ----------------- -----------
  Male sex                                    27 (60.0%)        58 (71.6%)        .183
  Age ≥ 60                                    17 (37.8%)        26 (32.1%)        .519
  ICH                                         18 (40.0%)        39 (48.1%)        .379
  Ischemic stroke                             13 (28.9%)        26 (32.1%)        .709
  Intracranial infection                      7 (15.6%)         10 (12.3%)        .613
  Complications and comorbidities             38 (84.4%)        69 (85.2%)        .911
  Paralysis                                   41 (91.1%)        62 (76.5%)        .043
   Hemiplegia                                 19 (42.2%)        42 (51.9%)        .300
   Quadriplegia                               14 (31.1%)        16 (19.8%)        .151
   Quadriparesis                              5 (11.1%)         6 (7.4%)          .707
   Paraplegia                                 3 (6.7%)          0 (0%)            .081
  Severe coma (GCS ≤ 8)                       13 (28.9%)        18 (22.2%)        .405
  Caprini score ≥ 3                           43 (95.6%)        77 (95.1%)        1.000
  Caprini score ≥ 5                           40 (88.9%)        72 (88.9%)        1.000
  Caprini score ≥ 9                           23 (51.1%)        43 (53.1%)        .832
  Hyperhomocysteinemia                        15 (33.3%)        28 (34.6%)        .889
  Raised [d]{.smallcaps}-dimer at admission   41 (91.1%)        62 (76.5%)        .043
  Raised [d]{.smallcaps}-dimer at 1 week      43 (95.6%)        77 (95.1%)        1.000
  Symptomatic of DVT                          2 (4.4%)          0 (0%)            .126
  Complications                               37 (82.2%)        54 (66.7%)        .062
   Pulmonary infection                        35 (77.8%)        46 (56.8%)        .018
   Tracheotomy                                6 (13.3%)         7 (8.6%)          .600
   Epilepsy                                   3 (6.7%)          4 (4.9%)          1.000
   Gastrointestinal bleeding                  5 (11.1%)         8 (9.9%)          1.000
   Electrolyte imbalance                      5 (11.1%)         2 (2.5%)          .105
   MODS                                       1 (2.2%)          3 (3.7%)          1.000
   Others                                     10 (22.2%)        13 (16.0%)        .390
  Comorbidities                               21 (46.7%)        44 (54.3%)        .410
   Hypertension                               19 (42.2%)        36 (44.4%)        .810
   Atrial fibrillation/flutter                2 (4.4%)          3 (3.7%)          1.000
   Diabetes                                   4 (8.9%)          7 (8.6%)          1.000
   Hepatitis B                                1 (2.2%)          6 (7.4%)          .417
   Coronary heart disease                     2 (4.4%)          2 (2.5%)          .940
  Age                                         56.1 ± 12.0       53.4 ± 13.7       .271
  GCS score                                   11.3 ± 3.4        11.5 ± 2.8        .812
  Caprini score                               8.7 ± 3.1         8.5 ± 2.9         .821
  Plasma HCY                                  14.9 ± 6.0        16.3 ± 12.2       .479
  [d]{.smallcaps}-Dimer at admission          6.3 ± 11.8        5.5 ± 15.3        .780
  [d]{.smallcaps}-Dimer at 1 week             4.4 ± 8.6         4.1 ± 9.0         .880

Abbreviations: DVT, deep venous thrombosis; GCS, Glasgow Coma Scale; HCY, homocysteine; ICH, intracerebral hemorrhage; MODS, multiple organ dysfunction syndrome.

###### 

Multivariate Logistic Regression Analysis of Risk Factors of Deep Vein Thrombosis.

![](10.1177_1076029620907954-table4)

  Variables                                   *P* Value   OR (95% CI)
  ------------------------------------------- ----------- ----------------------
  Paralysis                                   .055        3.162 (0.976-10.236)
  Raised [d]{.smallcaps}-dimer at admission   .090        2.785 (0.852-9.106)
  Pulmonary infection                         .058        2.290 (0.972-5.395)

Abbreviations: CI, confidence interval; OR, odds ratio.

In the univariate analysis of PE risk factors, percent of patients with paraplegia, femoral vein thrombosis, posterior tibial vein thrombosis, and pulmonary infection were significantly higher in the PE group ([Table 5](#table5-1076029620907954){ref-type="table"}). Use of multivariate logistic regression analysis revealed that paraplegia, femoral vein thrombosis, and pulmonary infection were independent risk factors for PE in NICU patients ([Table 6](#table6-1076029620907954){ref-type="table"}).

###### 

Univariate Analysis of Risk Factors of Pulmonary Embolism.
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  Variables                                   PE (+), n = 22   PE (−), n = 104   *P* Value
  ------------------------------------------- ---------------- ----------------- -----------
  Age ≥ 60                                    7 (31.8%)        36 (34.6%)        .802
  ICH                                         7 (31.8%)        50 (48.1%)        .164
  Ischemic stroke                             7 (31.8%)        32 (30.8%)        .923
  Intracranial infection                      5 (22.7%)        12 (11.5%)        .293
  Complications and comorbidities             20 (90.9%)       87 (83.7%)        .388
  Paralysis                                   17 (77.3%)       86 (82.7%)        .769
   Hemiplegia                                 6 (27.3%)        55 (52.9%)        .029
   Quadriplegia                               8 (36.4%)        22 (21.2%)        .128
   Quadriparesis                              2 (9.1%)         9 (8.7%)          1.000
   Paraplegia                                 2 (9.1%)         1 (1.0%)          .079
  Severe coma (GCS ≤ 8)                       6 (27.3%)        25 (24.0%)        .749
  Caprini score ≥3                            21 (95.5%)       99 (95.2%)        1.000
  Caprini score ≥5                            17 (77.3%)       95 (91.3%)        .125
  Caprini score ≥9                            12 (54.5%)       54 (51.9%)        .823
  Hyperhomocysteinemia                        9 (40.9%)        34 (32.7%)        .460
  Raised [d]{.smallcaps}-dimer at admission   20 (90.9%)       83 (79.8%)        .357
  Raised [d]{.smallcaps}-dimer at 1 week      21 (95.5%)       99 (95.2%)        .958
  Symptomatic of DVT                          1 (4.5%)         1 (1.0%)          .320
  DVT (+)                                     11 (50.0%)       34 (32.7%)        .124
   Trunk of deep vein                         3 (13.6%)        9 (8.7%)          .746
   Branch of deep vein                        8 (36.4%)        25 (24.0%)        .232
   Femoral vein                               3 (13.6%)        2 (1.9%)          .037
   Iliac vein                                 0 (0.0%)         1 (1.0%)          1.000
   Superficial femoral vein                   0 (0.0%)         1 (1.0%)          1.000
   Posterior tibial vein                      2 (9.1%)         1 (1.0%)          .079
   Fibular vein                               0 (0.0%)         1 (1.0%)          1.000
   Popliteal vein                             1 (4.5%)         0 (0.0%)          .175
   Muscular calf vein                         8 (36.4%)        26 (25%)          .275
   Internal jugular vein                      0 (0.0%)         1 (1.0%)          1.000
   Subclavian vein                            0 (0.0%)         1 (1.0%)          1.000
   Axillary vein                              0 (0.0%)         2 (1.9%)          1.000
   Brachial vein                              0 (0.0%)         3 (2.9%)          1.000
   Central venous catheter                    2 (9.1%)         4 (3.8%)          .618
  Complications                               19 (86.4%)       72 (69.2%)        .103
   Pulmonary infection                        18 (81.8%)       63 (60.6%)        .059
   Tracheotomy                                1 (4.5%)         12 (11.5%)        .553
   Epilepsy                                   3 (13.6%)        4 (3.8%)          .191
   Gastrointestinal bleeding                  2 (9.1%)         11 (10.6%)        1.000
   Electrolyte imbalance                      0 (0.0%)         7 (6.7%)          .459
   MODS                                       1 (4.5%)         3 (2.9%)          .541
   Others                                     1 (4.5%)         22 (21.2%)        .126
  Comorbidities                               9 (40.9%)        56 (53.8%)        .270
   Hypertension                               8 (36.4%)        47 (45.2%)        .448
   Atrial fibrillation/flutter                1 (4.5%)         4 (3.8%)          1.000
   Diabetes                                   3 (13.6%)        8 (7.7%)          .630
   Hepatitis B                                1 (4.5%)         6 (5.8%)          1.000
   Coronary heart disease                     0 (0.0%)         4 (3.8%)          1.000
   COPD                                       0 (0.0%)         5 (4.8%)          .586
  Age                                         55.4 ± 10.8      54.1 ± 13.6       .681
  GCS score                                   10.9 ± 3.1       11.5 ± 3.0        .347
  Caprini score                               8.3 ± 3.5        8.6 ± 2.8         .635
  Plasma HCY                                  16.8 ± 8.1       15.5 ± 10.9       .604
  [d]{.smallcaps}-Dimer at admission          12.2 ± 23.1      4.4 ± 11.0        .018
  [d]{.smallcaps}-Dimer at 1 week             7.3 ± 11.0       3.6 ± 8.2         .074

Abbreviations: COPD, chronic obstructive pulmonary disease; DVT, deep venous thrombosis; GCS, Glasgow Coma Scale; HCY, homocysteine; ICH, intracerebral hemorrhage; MODS, multiple organ dysfunction syndrome; PE, pulmonary embolism.

###### 

Multivariate Logistic Regression Analysis of Risk Factors of Pulmonary Embolism.
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  Variables                 *P* Value   OR (95% CI)
  ------------------------- ----------- ------------------------
  Paraplegia                .084        11.099 (0.726-169.604)
  Femoral vein thrombosis   .031        9.570 (1.235-74.150)
  Pulmonary infection       .066        3.241 (0.927-11.332)

Abbreviations: CI, confidence interval; OR, odds ratio.

Discussion {#section14-1076029620907954}
==========

Patients with neurological conditions such as paralysis and unconsciousness, especially those hospitalized in the NICU, have multiple VTE risk factors. Authors of previous studies have shown that DVT incidence in stroke patients is as high as 30% to 40%,^[@bibr9-1076029620907954]^ which is higher than for general surgical patients and similar to patients receiving knee or hip arthroplasty.^[@bibr10-1076029620907954]^ This is the first prospective observational study to report incidences of DVT and PE in a single-center NICU. According to our results, VTE incidence in NICU patients after 1 week of hospitalization is very high (35.7% with DVT and 17.5% with PE).

Diagnosis of DVT is usually informed by clinical symptoms and venous ultrasonography. Typical symptoms include swelling and pain in affected limbs, tortuous dilation of superficial veins, and Homan sign. Since coma and aphasia are common in NICU patients, the lack of self-reported symptoms contributed to the very low proportion of symptomatic DVTs in this study. Thus, venous ultrasonography, which is noninvasive, repeatable, and accurate, is necessary for DVT diagnosis. Ultrasound examination should extend from the proximal deep vein trunk to the distal branches in order to avoid a missed diagnosis. In our study, more than 75% of DVTs occurred in the muscular calf veins. Muscular calf vein thrombosis (MCVT) is considered a peripheral type of DVT. The thrombus forms and locates in the venous plexus of the gastrocnemius and soleus. Authors have previously reported that calf vein thrombosis accounted for 50% of all DVTs in the lower extremities, while MCVT accounted for 50% of the calf vein thrombosis.^[@bibr11-1076029620907954]^ In our study with NICU patients, the proportion of MCVT was much higher. Muscular calf vein thrombosis can further extend into the deep vein trunk and so form a more severe DVT. Additionally, they are a common source of pulmonary thrombosis.^[@bibr12-1076029620907954][@bibr13-1076029620907954]--[@bibr14-1076029620907954]^ In our study, 31.8% of PEs were associated with isolated MCVT.

Pulmonary embolism is one of the leading causes of sudden death in acute stroke patients. However, PE can easily be misdiagnosed. A low-risk PE, defined as an acute PE with the absence of the clinical markers of adverse prognosis which define massive or submassive PE,^[@bibr15-1076029620907954]^ can be asymptomatic or only lead to mild symptoms, which can be misdiagnosed as a severe pulmonary infection. In our study, 86.4% of PE patients had no definite symptoms, and diagnosis was made by CTPA. Compared to venous ultrasonography, CTPA is not routinely performed unless there is a strong suspicion of PE. This might be why screening with CTPA resulted in a much higher incidence of PE than in previous studies.^[@bibr6-1076029620907954]^ In our study, 77.3% of PEs occurred in the pulmonary artery branches. Patients did not have any clinical symptoms and were labeled as low-risk PE. Although relatively "low risk," these PEs are still at high risk of developing into a massive or submassive PE. In the current study, 24.4% of DVT patients had a PE, indicating that DVT patients are at high risk of developing PE. In contrast, 50% of PE patients had a DVT, reminding us that only screening for a PE in DVT patients may lead to missed diagnosis.

In a subgroup analysis of severe ICH patients, the incidence and characteristics of DVT and PE at 1 week of hospitalization were similar to the whole NICU group. The NCS VTE prophylaxis guidelines recommend use of IPC and/or graduated elastic compression stockings for severe ICH patients severe ICH.^[@bibr7-1076029620907954]^ They also suggest "using prophylactic doses of subcutaneous unfractionated heparin or LMWH to prevent VTE in patients with stable hematomas and no ongoing coagulopathy, starting within 48 hours after hospital admission."^[@bibr7-1076029620907954]^ However, this recommendation is only supported by a small number of low-quality studies.^[@bibr16-1076029620907954][@bibr17-1076029620907954][@bibr18-1076029620907954]--[@bibr19-1076029620907954]^ The safety of anticoagulant in ICH patients as well as its most suitable time, drug, and dose has always been controversial.^[@bibr20-1076029620907954]^ Thus, compliance with VTE prevention in the real world is insufficient. Authors of a study investigating nationwide trends of DVT prophylaxis after ICH in the United States reported that fewer than 20% of patients received anticoagulation, and the time of initiation was less than 48 hours in fewer than 50%.^[@bibr21-1076029620907954]^ In our study, LMWH was used for VTE patients with stable hematomas and no active bleeding. Neither extension of hematomas nor increased mortality was observed.

Both paralysis and pulmonary infection are independent risk factors for DVT and PE in NICU patients. Paralysis is commonly seen in patients with neurological diseases, while pulmonary infection is a ubiquitous complication of ICU patients. It has been suggested that ventilator-associated pneumonia occurs in as many as 30% of ICU patients requiring mechanical ventilation.^[@bibr22-1076029620907954]^ [d]{.smallcaps}-Dimer is an important exclusion indicator for VTE.^[@bibr23-1076029620907954]^ However, an elevated [d]{.smallcaps}-dimer level was detected in more than 90% of NICU patients in this study, indicating a relatively low specificity. It should be noted that the Caprini scoring system did not have a predictive value for VTE in the NICU patients. According to the Caprini score, more than 95% of patients were at higher/highest risk of VTE, thus revealing a weak distinguishing ability. The Caprini risk assessment model was established and validated with general surgery patients, with no critically ill patients included.^[@bibr24-1076029620907954],[@bibr25-1076029620907954]^ Therefore, an appropriate VTE risk assessment tool is needed for neurocritical care patients.

Our study has several limitations. First, it is a single-centered observational study with a limited sample size. Second, selection bias exists due to the disease spectrum of patients in our NICU. Traumatic brain injury patients are not routinely admitted to our neurology ICU. Third, some unstable and critically ill patients were not included, as per the exclusion criteria. Thus, the true incidence of PE may be underevaluated. Fourth, due to the complicated disease condition and contraindications as well as differing opinions of the attending neurologists, the strategy for chemical DVT prophylaxis was highly individualized. Finally, for patients who were unable to undergo CTPA, other diagnostic methods for PE, such as ventilation-perfusion scan and transesophageal echocardiography, were not carried out.

Conclusions {#section15-1076029620907954}
===========

Our study is the first to include incidences of DVT and PE in a single-center NICU. Even with preventative measures, VTE incidence in these NICU is very high. Most VTEs are asymptomatic, which could lead to a missed diagnosis. Researchers should pay attention to VTE events in critically ill neurological patients.
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